West Pharmaceutical Services has grown revenue 5.1% a year over three years and 5.7% a year over five, with earnings per share compounding at 4.4%. Revenue growth, 3-year annual rate: +5.1% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +5.7%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +4.4%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 18, FY2008 to FY2025, as filed.

WSTWest Pharmaceutical Services

Healthcare

$366.17+44% 1Y

$366.17

$230.7852 weeks$376.78

Is it growing?

Excellent

Growing: revenue growing +12% year on year, earnings up +17% year on year, and operating margin widening (+0.9 points).

3 good

Revenue trend+12% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +6% a year.

Earnings trend+17% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+0.9 points operating

Trailing-twelve-month operating margin, 20.4% now against 19.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is WST growing?

West Pharmaceutical Services has grown revenue 5.1% a year over three years and 5.7% a year over five, with earnings per share compounding at 4.4%.

+5.1%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +5.7%
Revenue growth, 5-year rate · +5.1% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +4.4%
Earnings per share, 3-year rate · revenue +5.1% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed